These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34797952)

  • 1. The likelihood of severe COVID-19 outcomes among PLHIV with various comorbidities: a comparative frequentist and Bayesian meta-analysis approach.
    Wang H; Jonas KJ
    J Int AIDS Soc; 2021 Nov; 24(11):e25841. PubMed ID: 34797952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV infection does not affect the risk of death of COVID-19 patients: A systematic review and meta-analysis of epidemiological studies.
    Favara G; Barchitta M; Maugeri A; Faro G; Agodi A
    J Glob Health; 2022 Aug; 12():05036. PubMed ID: 35972980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to "Methodological issues in the designing and reporting of frequentist and Bayesian meta-analysis to assess COVID-19 outcomes among PLHIV with various comorbidities" by Ram Bajpai, Vivek Verma and Gyan Prakash Singh.
    Wang H; Jonas KJ
    J Int AIDS Soc; 2022 Jun; 25(6):e25947. PubMed ID: 35678303
    [No Abstract]   [Full Text] [Related]  

  • 4. Methodological issues in the designing and reporting of frequentist and Bayesian meta-analysis to assess COVID-19 outcomes among PLHIV with various comorbidities.
    Bajpai R; Verma V; Singh GP
    J Int AIDS Soc; 2022 Jun; 25(6):e25946. PubMed ID: 35678304
    [No Abstract]   [Full Text] [Related]  

  • 5. Short Communication: Coronavirus Disease 19 Among People Living with HIV in Western India: An Observational Cohort Study.
    Pujari S; Gaikwad S; Chitalikar A; Dabhade D; Joshi K; Bele V
    AIDS Res Hum Retroviruses; 2021 Aug; 37(8):620-623. PubMed ID: 33913751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of COVID-19 hospitalisation by HIV-status and SARS-CoV-2 vaccination status during pre- and post-Omicron era in a national register-based cohort study in Sweden.
    Killander Möller I; Hedberg P; Wagner P; Lindahl H; Nyström S; Blixt L; Eketorp Sylvan S; Nilsdotter-Augustinsson Å; Österborg A; Fredrikson M; Hansson L; Kahn F; Sparén P; Gisslén M; Nauclér P; Bergman P; Aleman S; Carlander C
    Infect Dis (Lond); 2024 Sep; ():1-14. PubMed ID: 39320271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and outcomes of people living with HIV hospitalized with COVID-19: a nationwide experience.
    Ceballos ME; Ross P; Lasso M; Dominguez I; Puente M; Valenzuela P; Enberg M; Serri M; Muñoz R; Pinos Y; Silva M; Noguera M; Dominguez A; Zamora F;
    Int J STD AIDS; 2021 Apr; 32(5):435-443. PubMed ID: 33533294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Bayesian framework for estimating the risk ratio of hospitalization for people with comorbidity infected by SARS-CoV-2 virus.
    Gao X; Dong Q
    J Am Med Inform Assoc; 2021 Mar; 28(3):472-476. PubMed ID: 32986795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Outcomes among People Living with HIV in Colorado.
    Boyd M; Probst K
    AIDS Behav; 2024 Oct; 28(10):3249-3257. PubMed ID: 38916688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: systematic review with frequentist and Bayesian meta-analyses.
    Smadi M; Kaburis M; Schnapper Y; Reina G; Molero P; Molendijk ML
    Br J Psychiatry; 2023 Aug; 223(2):348-361. PubMed ID: 37183681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis.
    Lee KW; Yap SF; Ngeow YF; Lye MS
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33808066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France.
    Pourcher V; Gourmelen J; Bureau I; Bouee S
    PLoS One; 2020; 15(12):e0243529. PubMed ID: 33332394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study.
    Jassat W; Cohen C; Tempia S; Masha M; Goldstein S; Kufa T; Murangandi P; Savulescu D; Walaza S; Bam JL; Davies MA; Prozesky HW; Naude J; Mnguni AT; Lawrence CA; Mathema HT; Zamparini J; Black J; Mehta R; Parker A; Chikobvu P; Dawood H; Muvhango N; Strydom R; Adelekan T; Mdlovu B; Moodley N; Namavhandu EL; Rheeder P; Venturas J; Magula N; Blumberg L;
    Lancet HIV; 2021 Sep; 8(9):e554-e567. PubMed ID: 34363789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal and neonatal outcomes of COVID-19 in a high-risk pregnant cohort with and without HIV.
    De Waard L; Langenegger E; Erasmus K; Van der Merwe T; Olivier SE; Du Toit N; Paulsen C; Nkangana N; Van Niekerk M; Moodley A; Schell S; Taljaard J; Botha MH; Dramowski A; Cluver CA; Bekker A
    S Afr Med J; 2021 Dec; 111(12):1174-1180. PubMed ID: 34949304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 in people living with HIV: a single-center descriptive study.
    Pérez-Barragán E; Castillo-Flores JH; Mata-Marín JA; Franco López SG; Morales Martínez BA; Pérez Cavazos S
    J Infect Dev Ctries; 2022 Dec; 16(12):1796-1799. PubMed ID: 36753644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
    Yin T; Li Y; Ying Y; Luo Z
    BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
    Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
    Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis.
    Ng WH; Tipih T; Makoah NA; Vermeulen JG; Goedhals D; Sempa JB; Burt FJ; Taylor A; Mahalingam S
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of comorbidities among severe and non-severe COVID-19 patients in Asian versus non-Asian populations: A systematic review and meta-analysis.
    Puri A; He L; Giri M; Wu C; Zhao Q
    Nurs Open; 2022 Jan; 9(1):733-751. PubMed ID: 34761532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.